Biktarvy explained: inside the leading single-tablet regimen
A detailed look at the combination of bictegravir, emtricitabine, and tenofovir alafenamide, explaining how it achieves and maintains viral suppression.
DR
By Dr. Priya Sharma
Health Library · Condition Hub
ARV / HIV
Antiretroviral therapy explained: integrase inhibitors, NRTIs, adherence, and switching regimens.
3 articles
Showing
1–3
of 3
PrEP with emtricitabine/tenofovir: on-demand vs daily dosing
A guide to HIV Pre-Exposure Prophylaxis (PrEP), explaining how it works, who it is for, and the difference between daily and event-driven dosing strategies.
DR
By Dr. Jacob T.
Dolutegravir-based ART: what to expect in your first 90 days
Starting antiretroviral therapy can feel overwhelming. This guide covers what to expect in the first three months on a dolutegravir regimen.
DR
By Dr. Chitra Shetty